AstraZeneca's Evusheld nabs its first global nod as a COVID treatment

cafead

Administrator
Staff member
  • cafead   Aug 31, 2022 at 10:42: PM
via AstraZeneca’s COVID-19 antibody Evusheld nabbed its first global nod as a coronavirus treatment. Already authorized in many places to prevent infection prior to exposure, the drug is set to reach a broader set of patients in Japan.

article source
 

<